Cel-Sci
CVM
#9852
Rank
A$64.48 M
Marketcap
A$7.67
Share price
3.21%
Change (1 day)
-59.39%
Change (1 year)

Cel-Sci (CVM) - Total assets

Total assets on the balance sheet as of September 2025 : A$41.92 Million

According to Cel-Sci 's latest financial reports the company's total assets are A$41.92 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Cel-Sci - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-09-30A$42.59 M9.13%
2024-09-30A$39.02 M-17.82%
2023-09-30A$47.49 M-39.54%
2022-09-30A$78.55 M-25.13%
2021-09-30A$0.10 B85.49%
2020-09-30A$56.56 M38.28%
2019-09-30A$40.9 M-0.13%
2018-09-30A$40.95 M40.17%
2017-09-30A$29.21 M-10.32%
2016-09-30A$32.58 M-20.01%
2015-09-30A$40.73 M85.07%
2014-09-30A$22 M89.27%
2013-09-30A$11.62 M-25.05%
2012-09-30A$15.51 M-18.85%
2011-09-30A$19.11 M-51.23%
2010-09-30A$39.19 M-26.04%
2009-09-30A$53 M185.95%
2008-09-30A$18.53 M-20.03%
2007-09-30A$23.17 M79.13%
2006-09-30A$12.94 M217.79%
2005-09-30A$4.07 M-47.06%
2004-09-30A$7.69 M79.05%
2003-09-30A$4.29 M-38.07%
2002-09-30A$6.93 M-24.33%
2001-09-30A$9.16 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Curis
CRIS
A$41.15 M-1.83%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.66 B 1,485.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$134.21 B 320,051.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$1.29 B 2,985.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$59.34 B 141,455.71%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
A$287.10 B 684,720.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.17 B 5,089.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$9.19 M-78.08%๐Ÿ‡บ๐Ÿ‡ธ USA